Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.63 - $1.14 $54,505 - $98,629
-86,517 Reduced 69.03%
38,820 $32,000
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $121,150 - $203,359
108,170 Added 630.1%
125,337 $141,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $9,382 - $14,610
-7,162 Reduced 29.44%
17,167 $27,000
Q1 2023

May 09, 2023

SELL
$1.45 - $2.95 $12,855 - $26,154
-8,866 Reduced 26.71%
24,329 $37,000
Q4 2022

Feb 10, 2023

SELL
$2.02 - $3.25 $90,952 - $146,334
-45,026 Reduced 57.56%
33,195 $80,000
Q3 2022

Nov 10, 2022

BUY
$1.96 - $3.14 $26,469 - $42,405
13,505 Added 20.87%
78,221 $161,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $147,222 - $298,974
-113,248 Reduced 63.64%
64,716 $125,000
Q1 2022

May 12, 2022

BUY
$2.35 - $3.47 $319,600 - $471,920
136,000 Added 324.09%
177,964 $438,000
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $112,671 - $221,483
-38,586 Reduced 47.9%
41,964 $135,000
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $274,183 - $365,027
55,057 Added 215.97%
80,550 $423,000
Q2 2021

Aug 16, 2021

SELL
$2.56 - $5.49 $61,772 - $132,473
-24,130 Reduced 48.63%
25,493 $140,000
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $91,489 - $178,557
34,011 Added 217.85%
49,623 $135,000
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $545,842 - $773,133
-172,190 Reduced 91.69%
15,612 $50,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $439,827 - $767,483
147,593 Added 367.06%
187,802 $751,000
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $92,078 - $170,486
40,209 New
40,209 $158,000
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $276 - $632
-144 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$2.41 - $4.4 $616 - $1,126
-256 Reduced 64.0%
144 $1,000
Q3 2019

Nov 05, 2019

BUY
$2.17 - $3.14 $672 - $973
310 Added 344.44%
400 $1,000
Q2 2019

Aug 13, 2019

BUY
$2.53 - $3.04 $227 - $273
90 New
90 $0
Q1 2019

May 14, 2019

SELL
$2.51 - $3.73 $74,393 - $110,553
-29,639 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $33,959 - $56,812
21,358 Added 257.92%
29,639 $70,000
Q3 2018

Nov 13, 2018

BUY
$1.59 - $2.42 $13,166 - $20,040
8,281 New
8,281 $18,000
Q2 2018

Aug 15, 2018

SELL
$2.26 - $4.65 $15,801 - $32,512
-6,992 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.51 - $6.04 $12,330 - $21,218
3,513 Added 100.98%
6,992 $33,000
Q4 2017

Feb 09, 2018

SELL
$3.26 - $4.78 $20,534 - $30,109
-6,299 Reduced 64.42%
3,479 $11,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $34,027 - $43,414
9,778
9,778 $43,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.